Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Novocure Stock Is Jumping Today


Shares of Novocure Limited (NASDAQ: NVCR) are jumping 12.9% higher as of 11:09 a.m. ET on Thursday. The solid gain came after investment firm Truist Financial upgraded the stock from a hold to a buy recommendation. Truist kept its 12-month price target for the stock at $125, which represents upside potential of more than 70%.

Should investors buy Novocure because one analyst is more upbeat about its prospects? No. However, there are some compelling reasons Truist upgraded the healthcare stock to a buy recommendation.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments